- Sexually Transmitted Diseases
- Viral, Fungal, Bacterial & Protozoan STDs & Infections
- HIV/AIDS & STI Syndromes
- HIV/STD Testing and Diagnosis
- Infertility & Birth Defects
- Emerging and Re-emerging Infectious Diseases
- Cancers-STDs & Infections
- Reproductive & Pediatric Infectious Diseases
- Epidemiology of STD & Infectious Diseases
- STDs and Pregnancy
- Vaccines and Vaccination
- Prevention of mother to child transmission
- Immunology of Infectious Diseases
- Gene Editing approaches towards HIV
- Drug Discovery and Trending techniques
- Prevention &Treatment
- Global Market insights
- Ebola Outbreak and Prevention
- Zoonotic Diseases
- Public Awareness
Medical Professionals & Physicians
Nurse-practitioners & Pharmacists
Psychologists & Abuse, Behavioral specialists
Infectious diseases doctors & Public Health care Researchers
Social workers, AIDS service organization (ASO) staff
National government agencies and consultants
Epidemiologists, Bacteriologist, Retro-virologists, Microbiologists, Oncologists
Geneticist, Gynecologist, Clinical experts
Business experts / Manufactures & suppliers/ Aspiring Entrepreneurs, Sales Manager.
Media partners and Collaborators
International Delegates and global observers
Students and Young Researchers.
STD Congress 2019 Conference Opportunities
For Researchers and Faculty Members:
- Speaker Presentations
- Poster Display
- Symposium hosting (4-5-member team)
- Workshop organizing
For Universities, Associations & Societies:
- Association Partnering
- Collaboration proposals
- Academic Partnering
- Group Participation
For Students and Research Scholars:
- Poster Competition (Winner will get Best Poster Award)
- Young Researcher Forum (YRF Award to the best presenter)
- Student Attendee
- Group Registrations
For Business Delegates:
- Speaker Presentations
- Symposium hosting
- Book Launch event
- Networking opportunities
- Audience participation
For Business Entities :
- Exhibitor and Vendor Booths
- Sponsorship opportunities
- Product launch
- Workshop organizing
- Scientific Partnering
- Marketing and Networking with clients
Join us for a symphony of outstanding science, and enjoy the spectacular and unique beauty of Berlin, Germany.
Track 1 : Sexually Transmitted Diseases
STDs (or STIs) are infections that can mostly be passed on to another person during sex, be it anal, oral or vaginal sex. There are different types of STDs, from very benign to malignant and harmful ones. Nearly 20 different infections are known to be transmitted through sexual contact. Most STDs affect both men and women, but in many cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause serious health problems for the baby. More than 40 types of HPV can be spread sexually. If untreated, STIs can increase your risk of acquiring another STI such as HIV. Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi or parasites and can spread between individuals. There are almost 217 types of infectious diseases among them some are such as 'Common cold' include a number of distinct pathogens. Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines.
Depending on the type of disease, STDs can be spread with any type of sexual activity. STDs are most often caused by viruses and bacteria, both bacterial and viral STDs vary in their treatment. Bacterial STDs, such as gonorrhea, syphilis, and chlamydia, are often cured with antibiotics. However, viral STDs, such as HIV, HPV (genital warts), herpes, and hepatitis (the only STD that can be prevented with a vaccine), have no cure, but their symptoms can be alleviated with treatment. STDs, such as gonorrhea and syphilis, are classified as "reportable" because when diagnosed they must be reported to a proper health or government agency to prevent their spread. Gonorrhea, one of the most widespread of the STDs, is caused by the bacterium Neisseria gonorrhoeae, some strains of which are resistant to treatment by penicillin as well as the other drugs of choice. 80 percent of women and 40 percent of men diagnosed with chlamydia may not experiencesymptoms.
Track 3: HIV/AIDS & STI Syndromes
The syndromic approach is an important tool in the control of STIs and their sequelae, management by syndrome alone is inadequate because infections with important pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae may be present without any symptoms or findings. It is crucial to recognize syndromes that may be caused by one or more sexually transmitted pathogens and in managing STIs, diagnosis by syndrome and laboratory diagnosis by testing for specific organisms are both important and complementary. Diagnosis of a syndrome according to standard criteria predicts the likelihood that a specific pathogen or pathogens is/are present and thus facilitates initiation of appropriate empiric treatment at the first visit rather than deferring treatment until there is microbiological confirmation. WHO has developed simple flowcharts (also called algorithms) to guide health care providers in using the syndromic approach to manage seven syndromes.
Track 4: HIV/STD Testing and Diagnosis
The sexually transmitted diseases Testing Market is forecast to reach $167.4 billion by 2020, registering a CAGR of 8.5% during 2014-2020. STDs are a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out. Diagnostic testing programs are implemented by health care departments in developed regions for prevention and control of transmission, specifically of P&S Syphilis, Chlamydia, Gonorrhea and HPV. HPV testing volume and revenue will grow at much faster rate owing to higher incidences in Asia Pacific region.
Track 5: Infertility & Birth Defects
Abnormal development of the fetus resulting in death, malformation, growth retardation, and functional disorders is defined as birth defects. Approximately 150,000 babies are born each year with birth defects. Birth defects, including low birth weight babies, are the leading cause of infant mortality. Chlamydia, among the most common sexually transmitted diseases, affects an estimated 100,000 pregnant women each year, according to the Centers for Disease Control and Prevention. In fact, it's one of the leading causes of infections affecting newborns' eyes and respiratory system. Exposure to the bacteria during childbirth could lead to infection of the respiratory tract, causing infant pneumonia. While some types of birth defects have decreased, mainly through preventive methods, many have increased. According to a CDC study of 38 types of birth defects occurring over the period 1979-89, 27 had increased, including several cardiac defects, chromosomal defects such as trisomy 18, and fetal alcohol syndrome; 9 had remained the same; and only 2 had decreased.Premature birth of the baby which happens before 37 weeks of the pregnancy.Birth defects which is the abnormal shapes and function of the baby.
Emerging Infectious Diseases are those whose incidence or geographic range is rapidly increasing or threatens to increase in the near future. The rise of new infectious diseases or the re-emergence of the old infectious diseases is favored by many factors like evolution of the pathogens, human behavior and practice.
The emerging diseases can be established by its introduction into a population and its ability to spread from one person to another. Many emerging and re-emerging infectious diseases have been discovered like Hemorrhagic fever, Encephalitis, Zika virus & West nile virus etc.
Track 7: Cancers-STDs & Infections
Having an STD/STI increases a person's risk for several types of cancer. Certain high-risk types of human papillomavirus (HPV) can cause cervical cancer in women and other cancers including cancer of the vulva, vagina. In men, HPV infection can lead to the development of penile cancers. HPV also can cause cancers of the mouth, throat, and anus in both sexes. It can also cause oropharyngeal cancer. Acquiring viral hepatitis B or C puts a person at risk for liver cancer, and untreated HIV/AIDS increases risk for several types of rare cancers, including lymphomas, sarcomas, and cervical cancer. There are HPV tests that can be used to screen for cervical cancer. These tests are recommended for screening only in women aged 30 years and older. They are not recommended to screen men, adolescents, or women under the age of 30 years.
STI epidemiology and management have evolved interactively, particularly in developing countries. Technological advances in diagnosis, screening, and treatment; evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. Every year worldwide, there are approximately 357 million new infections of syphilis, chlamydia, gonorrhea, and trichomoniasis. A major recent advance in STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to help prevent genital and anal cancers in the foreseeable future.
Track 10 : STDs and Pregnancy
Women who are pregnant can become infected with the same STDs as women who are not pregnant. Pregnancy does not provide women or their babies any additional protection against STDs. STDs can complicate the pregnancy and may have serious effects on both mother and the developing baby. STDs/STIs during pregnancy can also cause Miscarriage, Ectopic pregnancy, Preterm labor and delivery, Birth defects and Newborn death etc. Some of these problems may be seen at birth; others may not be discovered until months or years later. Testing and treating pregnant women for STDs is a vital way to prevent serious health complications to both mother and baby that may otherwise happen with infection. STDs, such as chlamydia, gonorrhea, syphilis, trichomoniasis and BV can all be treated and cured with antibiotics that are safe to take during pregnancy.
Track 11 : Vaccines and Vaccination
Vaccines are the products that can produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism. Infectious Diseases Vaccines are the vaccines which prevent the Infectious Diseases and Infectious Diseases like Diphtheria, Hemophilic Influenzae Serotype B infection, HepatitisB, Measles,Meningitis, Mumps, Pertussis, Poliomyelitis, Rubella, Tetanus, Tuberculosis and Yellow Fever are preventable through vaccines.
Some STDs, such as such as gonorrhea, Chlamydia, and syphilis, are caused by bacteria. They are usually effectively treated with antibiotics. Several STDs can be effectively prevented through pre-exposure vaccination with widely available vaccines, including HAV, HBV, and HPV. Viral STDs are often highly persistent despite current therapeutic options or have no acceptable treatment available. Therefore, vaccines for certain viral STDs are in use, and others are in development.Researchers have developed vaccines for two sexually transmitted diseases. Ongoing efforts to develop vaccines for herpes and HIV may prove successful .
Track 12 : Prevention of mother to child transmission
HIV can be transmitted from an HIV-positive woman to her child during pregnancy, childbirth and breastfeeding. Mother-to-child transmission (MTCT), which is also referred to as ‘vertical transmission’, accounts for the vast majority of new infections in children. Prevention of mother-to-child transmission (PMTCT) provide antiretroviral treatment (ART) to HIV-positive pregnant women to stop their infants from acquiring the virus.The World Health Organization (WHO) promotes a comprehensive approach to PMTCT programmes which includes:
- Preventing new HIV infections among women of childbearing age
- Preventing unintended pregnancies among women living with HIV
- Preventing HIV transmission from a woman living with HIV to her baby
- Providing appropriate treatment, care and support to mothers living with HIV and their children and families.
2.3 million HIV infections were discovered globally. Large part of the population discovered with HIV infection discovered was in their reproductive stage and the men and women diagnosed with HIV were likely to want children. Perinatal transmission of HIV, also called as Vertical Transmission, occurs when HIV is infected from HIV-positive women to her baby during pregnancy, labor and delivery or breastfeeding. The percentage of transmission ranges from 15 to 45% during pregnancy, labor and delivery. The rate of transmission increases to additional 35 to 45% when there is breast feeding by the mother to child. The transmission rate depends on the type of STD and the mode of transfer.
Track 13: Immunology of Infectious Diseases
Whether an infectious disease agent is an “old acquaintance” or a new, emerging threat, the immune system’s battle against it is usually the first line of defense it encounters. With vaccines and effective treatments often unavailable, the immune system’s efforts to eradicate infectious agents or infected cells are frequently the only means to combat them. pathology of infections not eradicated by the immune system early on and the cunning strategies of the infectious microbes to evade immune attacks is followed by sections on immunogenetics and exploration of the immune system’s interventions against two high-incidence infections, tuberculosis and AIDS.
Track 14 : Gene Editing approaches towards HIV
Effective new quality altering procedures guarantee noteworthy open doors for novel remedial alternatives to important illnesses, including cancer, genetic disorders and viral infections. Techniques like zinc finger nuclease, transcription activator-like effector nucleases and clustered regulatory interspaced short palindromic repeat.
Track 15 : Drug Discovery and Trending techniques
With the newer diagnostic technologies, we are on the verge of a major change in the approach to STI control. When diagnostic methods are faster and results more accurate, they are bound to improve patient care. The molecular techniques are useful for microorganisms that are difficult to culture. They have a fairly recent history of just over 40 years. They are increasingly being accepted by clinicians as viable options in their practice. Aseptic technique is normally applied to prevent the infections caused by different means.
Track 16 : Prevention &Treatment
Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. STI control efforts have increasingly been defined in relation to HIV programme priorities that are funded, implemented and evaluated independently of other STI control efforts. STI control is a public health outcome, measured as reduced incidence and prevalence, achieved by implementing strategies composed of multiple synergistic interventions.
Track 17 : Global Market insights
Sexually transmitted diseases(STDs) remain a major public health challenge in the world. Biological factors place women at greater risk than men for the severe health consequences of STDs. The two most commonly reported infectious diseases in America is chlamydia and gonorrhea which pose a particular risk to the health of women, as both can result in infertility if left untreated. Trends of STD are more toward viral origin as compare to bacterial origin. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.
Track 18 : Ebola Outbreak and Prevention
Ebola hemorrhagic caused by virus belonging to the family Filoviridae which is also called as Filovirus. This virus is also known as Zoonotic Virus as it is transmitted from animals to humans. This disease was first appeared in 1976 in 2 simultaneous outbreaks but the largest outbreak was discovered in West Africa which was also the most complex outbreak from the time it was discovered. Fruit bats of the Pteropodidae family are natural Ebola virus hosts the transmission is done from the by the close contact with the blood.
Track 19 : Zoonotic Diseases
The transfer of the pathogens causing the diseases can be form one person to another. But when the disease is transferred from animals to humans the disease is been termed as zoonotic diseases. The mode of transfer of the infectious agents can be in many ways like direct contact, indirect contact, vector-borne, food borne.
- Routes of Transmission and Mechanism
- Molecular genetic of Zoonotic Diseases
- Symptoms and Drug treatment
Track 20 : Public Awareness
Sexually transmitted Infections (STIs) rank among the most important health issues for the people especially the young adults worldwide. The development of educational programs will play vital role in the fight to control sexually transmitted diseases. The Sexually Transmitted Disease (STD) infection prevention and control program works to reduce the incidence of sexually transmitted diseases. Social media practices to help implement awareness strategies. Awareness was generally high for HIV/AIDS (above 90%) and low for HPV (range 5.4%-66%). By providing screening, testing, diagnosis and treatment for infected individuals, the STD program is fighting the war against sexually transmitted diseases one person at a time. STDs can be simply prevented with three actions (a) Talk openly to partners, patients, and healthcare providers about sexual health and STDs, (b) Ensure everyone knows who should be tested and when, (c) The important role healthcare providers and patients play in making sure STDs are treated correctly.
8th Asia Pacific STD and Infectious Diseases Congress, November 12-13, 2018, Tokyo Japan | 2nd International Conference on Sexually Transmitted Diseases, December 03-04, 2018, Toronto, Canada | 2nd International Conference on Worldwide Infectious Diseases, December 03-04, 2018,Madrid, Spain | 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, July 01-02, 2019 Valencia, Spain | 4th World congress on Virology and Bacteriology, February 25-26 2019, Berlin, Germany | 6th International Congress on Infectious Diseases, Feb 25-26, 2019 London, United Kingdom | 12th World Congress on Virology and Infectious Diseases, March 13-14, 2019, Singapore | 7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA | 14th International Conference on Infectious Diseases, Prevention and Control, March 21-22, 2019 Dubai, UAE | 2nd Global experts meet on STD-AIDS and Infectious Diseases, April 08-09, 2019 Wellington, New Zealand | 3rd International Conference on Influenza and Emerging Infectious Diseases, April 10-11, 2019 Toronto, Ontario, Canada | World Conference on Bacteriology and Infectious Diseases, April 17-18, 2019 Amsterdam, Netherlands | 3rd International Conference on Chronic Diseases, May 20-21, 2019 London, UK | 5th International Conference on Influenza and Zoonotic Diseases, June 17-18, 2019 Berlin, Germany | 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, July 01-02, 2019 Valencia, Spain | 10th International Conference on Emerging Infectious Diseases, September 16-17, 2019 Brussels, Belgium
Europe: Spanish Society of Paediatric Infectious Diseases, Spain | Spanish Society of Paediatric Clinical immunology and Allergy, Spain | Spanish Association of Paediatric Primary Care, Spain, British Society for Immunology, U.K | European Society for Immunodeficiencies, Switzerland | European Society of Clinical Microbiology and Infectious Diseases, Switzerland | British Society for Antimicrobial Chemotherapy, UK | Society for General Microbiology, UK, European AIDS Clinical Society / EACS BELGIUM, AIDS Action Europe Berlin, Germany, International AIDS Society, Switzerland, National Association of People Living With HIV/AIDS, European AIDS Clinical, UNAIDS, BHIVA, Deutsche AIDS Gesellschaft, German, International Union against Sexually Transmitted Infections (IUSTI), European Society for Immunodeficiencies, Association of Nurses in AIDS Care
USA: Centers for Disease Control and Prevention (CDC), Infectious Disease Association of California, USA; Infectious Diseases Society of America, USA, The Association for Professionals in Infection Control and Epidemiology, Inc, USA, HIV.gov, USA, National AIDS Commission, HIV Medicine Association, American Sexually Transmitted Diseases Association (ASTDA), International Society for Infectious Diseases, Centers for AIDS Research (CFAR), Canadian Public Health Association, American Sexually Transmitted Diseases Association (ASTDA)
Asia Pacific: Infectious Diseases Association of Thailand, Thailand; Pediatric Infectious Diseases Society for Thailand, Thailand | The Swiss Society for Infectious Diseases, Switzerland, Society of Infectious Disease, Singapore, New South Wales Infection Control Association, Australia | Philippine Hospital Infection Control Society, Philippine; New South Wales Infection Control Association, Australia | Victorian Infection Control Association, Australia | Victorian Infection Control Professionals Association, Australia | Infection Control Practitioners Association of Queensland, Australia.
Scope and Importance of STD & Infectious disease Research
Sexually transmitted infections (STIs) and Re-emerging infections pose a significant threat to individual and public health. Sexually transmitted infections (STIs) have a wide range of negative consequences on individual health, ranging from physical discomfort to infertility, malignancy, severe maternal and fetal pregnancy complications, and loss of life.
According to recent statistical it was reported the abrupt increase in the death case studies was due to spread of infectious diseases and this infection and spreading could be prevented with the help of Health care professionals. Contamination aversion and control measures expect to guarantee the assurance of the individuals who may be powerless against procuring a disease. STDs are an important global health priority because of their devastating impact on women and infants and their inter-relationships with HIV/AIDS. STDs and HIV are linked by biological interactions in which infections can occur in the same populations. Infection with certain STDs can increase the risk of getting and transmitting HIV as well as alter the way the disease progresses. In addition, STDs can cause long-term health problems, particularly in women and infants. Some of the health complications that arise from STDs include pelvic inflammatory disease, infertility, tubal or ectopic pregnancy, cervical cancer, and perinatal or congenital infections in infants born to infected mothers. The global concerns of sexually transmitted infections (STIs) remains at the higher edge.
Why in Germany?
Despite increasing numbers of new infections with STIs, the limited existing research indicates a considerable ignorance regarding the existence and dangers of STIs other than HIV in Germany. HIV/AIDS has been a global phenomenon due to the delay in the research, development and health care sector. One study found that in a representative sample of adults across Germany, a majority had never heard of syphilis, gonorrhoea, hepatitis, genital herpes, chlamydia, and HPV. Only 6% were aware of HPV and 14% of chlamydia as the two most frequent viral and bacterial STIs. One of the reason for this large-scale ignorance might be that STIs other than HIV escaped the attention of German public health authorities and sexual health educators for a long time.
The diagnostic testing of STDs is estimated to grow at a CAGR of 8.5% over the forecast period 2014-2020 to reach market size of $167.4 billion in 2020. The test volume will rise to 5,520 million in 2020.
In 2017, an estimated 2.2 million people were living with HIV in Western and Central Europe and North America.1 The annual number of new HIV infections among adults in the region remained stable between 2010 and 2015, but dropped by almost 20,000 in 2016 to 73,000. More than half of all new HIV infections occurred in the USA, and more than a quarter occurred in six countries: France, Germany, Italy, Spain, Turkey and the UK
Segments for sexually transmitted diseases drugs market as:
Drug Market by Disease Type
Drug Market by Therapy Class
Drug Market by Distribution Channel
Public Health Labs
Drug Market, by Geography
Middle East & Africa
Increase in the Global STD diagnostics market, by types, 2012-2022, (USD Billion)
STD Congress 2019 conference has been fostering the need to control the impact of permanent sexually transmitted infections within the public health environment. Bacterial STIs include gonorrhea, chlamydia, and syphilis while viral STIs include genital herpes, HIV, genital warts (HPV), and hepatitis. The microorganisms causing STIs reside in blood, semen, and vaginal fluid. STDs caused by chlamydia dominated the overall market in terms of revenue and was valued at around USD 6.00 billion in 2014. However, diagnosis of sexually transmitted diseases caused by syphilis is rising and is estimated to account for over 20% of the market by 2022, growing at a healthy CAGR over the forecast period due to increasing prevalence of syphilis infections worldwide.
Fund Allotment to STD and Infectious diseases Research
Domestic funding is STD and infectious disease spending, by country governments in their national budgets. The Global Fund , The World Bank , The United Nations are the Key Multilateral funding Institutions Involved in STD, HIV/AIDS and other infectious diseases. Historically, the HIV response has been largely funded by international donors and governments, but low- and middle-income countries are now beginning to lead on efforts to finance their STD response. The President’s Emergency Plan for AIDS Relief (PEPFAR), USA-WHO accounted for the majority of bilateral and multilateral funding from donor governments in 2017 (US$4.9 billion), followed by the United Kingdom (UK) (US$645.6 million), France (US$242.4 million), the Netherlands (US$214.2 million) and Germany (US$182 million), these five countries have accounted for roughly 80% of all HIV funding from donor governments.
Private funders The charitable and corporate philanthropic organisations provided US$680 million for global STD,HIV and AIDS programmes in 2017.The largest funders — The Bill and Melinda Gates Foundation and Gilead Sciences ViiV Healthcare, Aidsfonds, Kaiser Family Foundation and Elton John AIDS Foundation.
African Union (AU) endorses major new initiatives to end up AIDS by 2030 .The Joint United Nations Programme on STD and Infectious diseases (UNAIDS)with Abuja Declaration leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNITAID, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank which works closely with global and national partners towards ending the STD, HIV and AIDS epidemic by 2030 as part of the Sustainable Development.
UC San Diego AIDS Research Institute
The Elton John AIDS Foundation
Treatment Action Campaign
The Rush Foundation
AmfAR ; Lifespan/Tufts/Brown Center for AIDS Research
ViiV Healthcare :
GeoVax Labs, Inc.
Delaney AIDS Research Enterprise (DARE)
AIDS Research Alliance
Lifespan/Tufts/Brown Center for AIDS Research
UC San Diego AIDS Research Institute
The Scripps Research Institute
Gilead Sciences : Pfizer INC, Hoffmann La Roche, Bayer Healthcare, Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb Co. AbbVie, Inc., Gilead Sciences, GlaxoSmithKline Plc, and Merck & Co., Inc.
Bristol-Myers Squibb : AIDS Research Alliance : Delaney AIDS Research Enterprise (DARE); GeoVax Labs, Inc. Boehringer Ingelheim Pharmaceuticals ; Carol Enters List Co. (CELCO) ; Steven A. and Alexandra M. Cohen Foundation; Wasserman Foundation